← FDA Drug Approvals (Drugs@FDA)

NABUMETONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2008-03-07

Drug application

FDA Application #

ANDA078671

Application type

Abbreviated New Drug Application (Generic)

Brand name

NABUMETONE

Generic name

NABUMETONE

Active ingredients

NABUMETONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Exelan Pharmaceuticals Inc.

First approval

2008-03-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown